BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 12538668)

  • 21. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin.
    Dorman SC; Babirad I; Post J; Watson RM; Foley R; Jones GL; O'Byrne PM; Sehmi R
    J Allergy Clin Immunol; 2005 Mar; 115(3):501-7. PubMed ID: 15753896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A coordinated change in chemokine responsiveness guides plasma cell movements.
    Hargreaves DC; Hyman PL; Lu TT; Ngo VN; Bidgol A; Suzuki G; Zou YR; Littman DR; Cyster JG
    J Exp Med; 2001 Jul; 194(1):45-56. PubMed ID: 11435471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
    Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
    J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
    Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.
    Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D
    PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
    PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W; Liu Y; Zhou W; Si L; Ren L
    PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
    Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
    Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
    Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
    J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy.
    Huang Y; Zhu XY; Du MR; Li DJ
    J Immunol; 2008 Feb; 180(4):2367-75. PubMed ID: 18250446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis.
    Burman A; Haworth O; Hardie DL; Amft EN; Siewert C; Jackson DG; Salmon M; Buckley CD
    J Immunol; 2005 Feb; 174(3):1693-700. PubMed ID: 15661933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
    Deng L; Chen N; Li Y; Zheng H; Lei Q
    Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells.
    Beaulieu S; Robbiani DF; Du X; Rodrigues E; Ignatius R; Wei Y; Ponath P; Young JW; Pope M; Steinman RM; Mojsov S
    J Immunol; 2002 Sep; 169(6):2925-36. PubMed ID: 12218106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation.
    Nagase H; Miyamasu M; Yamaguchi M; Fujisawa T; Ohta K; Yamamoto K; Morita Y; Hirai K
    J Immunol; 2000 Jun; 164(11):5935-43. PubMed ID: 10820276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
    Isozaki T; Arbab AS; Haas CS; Amin MA; Arendt MD; Koch AE; Ruth JH
    Arthritis Rheum; 2013 Jul; 65(7):1736-46. PubMed ID: 23633118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
    Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human gingival fibroblasts express functional chemokine receptor CXCR6.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2009 Jun; 156(3):413-8. PubMed ID: 19438592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.